[
  {
    "vignette_index": 1075,
    "input": "Viral Conjunctivitis secondary to systemic viral illness (likely influenza or adenovirus) END",
    "output": "THINKING: Use systematic clinical reasoning to develop your treatment approach:  STEP 1 - DIAGNOSIS CONFIRMATION & SEVERITY ASSESSMENT: Primary diagnosis confidence: High, given systemic viral illness symptoms and conjunctivitis presentation; confirmed further by laboratory testing for Influenza A H5. Severity classification: Moderate to severe, considering high fever (>101\u00b0F), systemic symptoms worsening, and significant discomfort. Urgency level: Urgent care required due to systemic illness severity and potential complications. Differential considerations: Bacterial conjunctivitis (less likely without purulent discharge), other viral causes, or ocular complications like keratitis.  STEP 2 - EVIDENCE-BASED TREATMENT SELECTION: First-line treatment per guidelines: Supportive care for viral conjunctivitis; antiviral treatment for Influenza A when indicated. Supporting evidence: Antivirals like oseltamivir reduce disease duration if started early; supportive measures relieve symptoms. Patient-specific considerations: Anxiety levels warrant clear communication; systemic influenza management required. Contraindications or cautions: Allergy to antivirals; monitor for adverse effects.  STEP 3 - PHARMACOLOGICAL INTERVENTIONS: Primary medication choice: Oseltamivir 75 mg twice daily for 5 days. Rationale for selection: Expressed confirmed influenza A H5; oseltamivir is effective if started within 48 hours but may still benefit later. Expected timeline for improvement: Symptoms may improve within 48-72 hours; systemic symptoms may take longer. Key side effects to monitor: Nausea, vomiting, neuropsychiatric effects (rare). Alternative medications if first-line fails: Zanamivir or peramivir (if oseltamivir contraindicated).  STEP 4 - NON-PHARMACOLOGICAL INTERVENTIONS: Primary non-drug interventions: Rest, hydration, ocular hygiene (warm compresses), avoiding eye touching. Patient education priorities: Importance of hygiene to prevent spread, symptom monitoring, when to seek urgent care. Lifestyle modifications: Adequate sleep, balanced nutrition, minimize exposure to others. Behavioral interventions: Use of eye protection, stress management techniques to reduce anxiousness.  STEP 5 - MONITORING & FOLLOW-UP STRATEGY: Follow-up timeline: Re-evaluate in 48-72 hours or sooner if worsening symptoms. Monitoring parameters: Fever reduction, respiratory status, ocular symptoms clarity. Red flag symptoms: Increasing ocular pain, vision changes, difficulty breathing, persistent high fever. Treatment response assessment: Reduction in systemic and ocular symptoms, patient reassurance.  STEP 6 - PATIENT COMMUNICATION STRATEGY: Communication approach: Clear, empathetic explanation of illness, emphasizing supportive care and importance of medication adherence. Addressing patient concerns: Reassure that symptoms should improve with treatment; validate anxiety but provide factual information. Adherence strategies: Simplify medication instructions; schedule follow-ups; provide written materials. Family involvement: Encourage informing close contacts about illness to prevent spread.  STEP 7 - COORDINATION & REFERRALS: Specialist referrals needed: Ophthalmology if ocular symptoms worsen or new ocular pain/vision changes occur. Other healthcare team members: Primary care nurse for follow-up, possibly infectious disease specialist if complications arise. Community resources: Influenza educational resources, support groups for anxious patients. Insurance/cost considerations: Discuss medication costs, explore assistance programs if needed.\nANSWER: Based on the diagnosis of viral conjunctivitis secondary to systemic influenza A H5 virus infection, I recommend a comprehensive treatment approach that combines evidence-based medical management with patient-centered care strategies. The treatment plan includes initiating antiviral therapy with oseltamivir 75 mg twice daily for 5 days, along with supportive measures such as rest, hydration, ocular hygiene, and symptomatic relief. Careful monitoring of symptoms will be essential, with follow-up in 48-72 hours to assess response and identify any emerging complications. Patient education will focus on hygiene practices, symptom management, and when to seek urgent care. This approach aims to reduce systemic illness severity, limit ocular discomfort, and prevent transmission, while addressing the patient's anxiety through clear communication and reassurance. Long-term management emphasizes continued supportive care and prompt referral if ocular or systemic symptoms worsen.",
    "gold_diagnosis": "Influenza A H5 virus"
  }
]